Prof dr Jolanda de Vries

Professor de Vries is a tumor immunologist at the Radboud University Medical Center in Nijmegen. She was amongst the first worldwide who introduced tumour antigen-loaded dendritic cell (DC)-based vaccines in the clinic. She was the first to track the migratory behaviour of dendritic cells in patients, demonstrating how important the route of administration can be to maximize the capacity of cellular vaccines to boost anti-cancer immunity.

Prof dr Joachim Aerts

Professor Aerts is a Pulmonologist and Medical Oncologist at the Erasmus Medical Centre in Rotterdam, with specialization in lung cancer and mesothelioma (asbestos cancer). He is developing immunotherapy for these incurable diseases and has special interest and long experience in dendritic cell vaccination in both preclinical and clinical studies.

Prof dr John Haanen

Professor Haanen specializes in Internal Medicine with emphasis on medical oncology in the Antoni van Leeuwenhoek (AVL) as well as researcher at the department immunotherapy of the Dutch Cancer Institute. He is an expert in treatment of patients with metastasized melanoma (skin cancer) or kidney cancer. His research also focuses on enhancing the immune response against these types of cancer. Finally, he coordinates multi-center clinical trials for many new immunotherapeutics.